The present invention relates to methods and compositions for treating a subject having cancer comprising administering an effective amount of pemetrexed and a compound of formula (I): PR, wherein P is a targeting group which binds to the reactive site of a post proline-cleaving enzyme, and wherein R is a reactive group which reacts with thre reactive site of a post proline-cleaving enzyme. Particularly preferred compound of Formula (I) are boroproline compounds, such as Ile-boroPro and Val-boroPro.
申请公布号
WO2007059099(A3)
申请公布日期
2009.04.30
申请号
WO2006US44130
申请日期
2006.11.14
申请人
POINT THERAPEUTICS, INC.;ADAMS, SHARLENE;JONES, BARRY;UPRICHARD, MARGARET, J.
发明人
ADAMS, SHARLENE;JONES, BARRY;UPRICHARD, MARGARET, J.